BCYC
Price
$4.27
Change
+$0.07 (+1.67%)
Updated
Jun 4 closing price
Capitalization
293.21M
62 days until earnings call
Intraday BUY SELL Signals
CADL
Price
$9.27
Change
+$0.47 (+5.34%)
Updated
Jun 4 closing price
Capitalization
678.85M
75 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCYC vs CADL

Header iconBCYC vs CADL Comparison
Open Charts BCYC vs CADLBanner chart's image
BCYC vs CADL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BCYC vs. CADL commentary
Jun 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and CADL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2026
Stock price -- (BCYC: $4.27 vs. CADL: $9.27)
Brand notoriety: BCYC and CADL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 58% vs. CADL: 145%
Market capitalization -- BCYC: $293.21M vs. CADL: $678.85M
BCYC [@Biotechnology] is valued at $293.21M. CADL’s [@Biotechnology] market capitalization is $678.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $112.12B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileCADL’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • CADL’s FA Score: 0 green, 5 red.
According to our system of comparison, both BCYC and CADL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while CADL’s TA Score has 5 bullish TA indicator(s).

  • BCYC’s TA Score: 4 bullish, 5 bearish.
  • CADL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CADL is a better buy in the short-term than BCYC.

Price Growth

BCYC (@Biotechnology) experienced а -8.57% price change this week, while CADL (@Biotechnology) price change was +14.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.88%. For the same industry, the average monthly price growth was -2.20%, and the average quarterly price growth was +3.33%.

Reported Earning Dates

BCYC is expected to report earnings on Aug 06, 2026.

CADL is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (-2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CADL($679M) has a higher market cap than BCYC($293M). CADL YTD gains are higher at: 63.982 vs. BCYC (-39.689). CADL has higher annual earnings (EBITDA): -50.3M vs. BCYC (-211.5M). BCYC has more cash in the bank: 559M vs. CADL (195M). BCYC has less debt than CADL: BCYC (15.3M) vs CADL (49.3M). BCYC has higher revenues than CADL: BCYC (63.5M) vs CADL (0).
BCYCCADLBCYC / CADL
Capitalization293M679M43%
EBITDA-211.5M-50.3M421%
Gain YTD-39.68963.982-62%
P/E RatioN/AN/A-
Revenue63.5M0-
Total Cash559M195M287%
Total Debt15.3M49.3M31%
FUNDAMENTALS RATINGS
BCYC: Fundamental Ratings
BCYC
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCCADL
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
87%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 8 days ago
79%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 18 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
BCYC
Daily Signal:
Gain/Loss:
CADL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AABPX12.290.10
+0.82%
American Beacon Balanced Inv
VWIGX37.58N/A
N/A
Vanguard International Growth Inv
OBIOX26.17N/A
N/A
Oberweis International Opps Inv
HMVTX20.03N/A
N/A
Hartford MidCap Value R5
CCRIX35.34N/A
N/A
Columbia Small Cap Growth R

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with DNLI. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+1.67%
DNLI - BCYC
51%
Loosely correlated
+2.49%
NGNE - BCYC
48%
Loosely correlated
+4.88%
NRIX - BCYC
47%
Loosely correlated
-1.29%
PCVX - BCYC
47%
Loosely correlated
+3.84%
BHVN - BCYC
47%
Loosely correlated
+5.46%
More

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with AURA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
+5.28%
AURA - CADL
47%
Loosely correlated
-1.31%
RXRX - CADL
43%
Loosely correlated
+9.22%
CRBU - CADL
43%
Loosely correlated
+3.25%
MGX - CADL
41%
Loosely correlated
N/A
BCYC - CADL
40%
Loosely correlated
+1.67%
More